Reduction in adverse symptoms as blood pressure becomes controlled

Pharmacotherapy

Volumn 28, Issue 9, 2008, Pages 1104-1114

  Weber, Cynthia A ^a   Leloux, Megan R ^a   Carter, Barry L ^a,b   Farris, Karen B ^a   Xu, Yinghui ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

ADR; Adverse drug reaction; Hypertension; Self efficacy; Social support; Symptoms

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PHARMACIST; PHYSICIAN; SOCIAL SUPPORT; STRUCTURED QUESTIONNAIRE; SYMPTOM; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; QUESTIONNAIRES; SELF EFFICACY; SOCIAL SUPPORT; YOUNG ADULT;

EID: 51849164524     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.9.1104     Document Type: Article

References (36)

1. Ross SD, Akhras KS, Zhang S, Rozinsky M, Nalysnyk L. Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis. Pharmacotherapy 2001;21:940-53.
2. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997;10(7pt 1):697-704.
3. Degli Esposti E, Sturani A, Di Martino M, et al. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 2002;16:439-44.
4. Degli Esposti L, Degli Esposti E, Valpiani G, et al. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy Clin Ther 2002;24:1347-57; discussion 1346.
5. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363:2022-31.
6. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-72.
7. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002;288:2981-97. (Errata in JAMA 2003;289:178 and JAMA 2004;291:2196.)
8. Erickson SR, Williams BC, Gruppen LD. Perceived symptoms and health-related quality of life reported by uncomplicated hypertensive patients compared to normal controls. J Hum Hypertens 2001;15:539-48.
9. Neaton JD, Grimm RH Jr, Prineas RJ, et al, for the Treatment of Mild Hypertension Study Research Group. Treatment of mild hypertension study: final results. JAMA 1993;270:713-24.
10. Materson BJ, Reda DJ, Cushman WC, et al, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-21.
11. Anderson RT, Hogan P, Appel L, Rosen R, Shumaker SA. Baseline correlates with quality of life among men and women with medication-controlled hypertension: the trial of nonpharmacologic interventions in the elderly (TONE). J Am Geriatr Soc 1997;45:1080-5.
12. Bulpitt CJ, Dollery CT, Carne S. Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976;38:121-8.
13. Hollenberg NK, Williams GH, Anderson R. Medical therapy, Symptoms, and the distress they cause: relation to quality of life in patients with angina pectoris and/or hypertension. Arch Intern Med 2000;160:1477-83.
14. Erickson SR, Williams BC, Gruppen LD. Relationship between symptoms and health-related quality of life in patients treated for hypertension. Pharmacotherapy 2004;24:344-50.
15. Sarason IG, Sarason BR, Shearin EN. Social support as an individual difference variable: its stability, origins, and relational aspects. J Pers Soc Psychol 1986;50:845-55.
16. Sarason IG, Sarason BR. Concomitants of social support: attitudes, personality characteristics, and life experiences. J Pers 1982;50:331-44.
17. Doherty WJ, Schrott HG, Metcalf L, Iasiello-Vailas L. Effect of spouse support and health beliefs on medication adherence. J Fam Pract 1983;17:837-41.
18. Reblin M, Uchino BN. Social and emotional support and its implication for health. Curr Opin Psychiatry 2008;21:201-5.
19. Bandura A, Jeffery RW, Wright CL. Efficacy of participant modeling as a function of response induction aids. J Abnorm Psychol 1974;83:56-64.
20. Bandura A. Self-efficacy changing societies. New York: Cambridge University Press; 1995.
21. Bandura A, Jourden EJ. Self-regulatory mechanisms governing the impact of social comparison on complex decision making. J Pers Soc Psychol 1991;60:941-51.
22. Bandura A, Reese L, Adams NE. Microanalysis of action and fear arousal as a function of differential levels of perceived self-efficacy. J Pers Soc Psychol 1982;43:5-21.
23. De Geest S, Abraham I, Gemoets H, Evers G. Development of the long-term medication behaviour self-efficacy scale: qualitative study for item development. J Adv Nurs 1994;19: 233-8.
24. Fuertes JN, Mislowack A, Bennett J, et al. The physician-patient working alliance. Patient Educ Couns 2007;66:29-36.
25. Carter B, Bergus G, Dawson J, et al. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich) 2008;10:260-71.
26. Kaboli P, Hoth A, Carter B. The VA enhanced pharmacy outpatient clinic (EPOC) study: a randomized-controlled pharmacist-physician intervention trial [abstract]. J Gen Intern Med 2004;19:227.
27. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals. I. Blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension 2005;45:142-61.
28. Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002;288:2421-31.
29. Von Muenster SJ, Carter BL, Weber CA, et al. Description of pharmacist interventions during physician-pharmacist co-management of hypertension. Pharm World Sci 2008;30: 128-35.
30. Denhaerynck K, Abraham I, Gourley G, et al. Validity testing of the long-term medication behavior self-efficacy scale. J Nurs Meas 2003;11:267-82.
31. Curtin RB, Walters BA, Schatell D, Pennell P, Wise M, Klicko K. Self-efficacy and self-management behaviors in patients with chronic kidney disease. Adv Chronic Kidney Dis 2008;15: 191-205.
32. Seeman TE. Social ties and health: the benefits of social integration. Ann Epidemiol 1996;6:442-51.
33. Hanson BS, Isacsson SO, Janzon L, Lindell SE. Social network and social support influence mortality in elderly men: the prospective population study of "Men born in 1914," Malmo, Sweden. Am J Epidemiol 1989;130:100-11.
34. House JS, Landis KR, Umberson D. Social relationships and health. Science 1988;241:540-5.
35. Berkman LF, Syme SL. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol 1979;109:186-204.
36. Rodriguez-Artalejo F, Guallar-Castillon P, Herrera MC, et al. Social network as a predictor of hospital readmission and mortality among older patients with heart failure. J Card Fail 2006;12:621-7.